Establishment Labs Holdings Inc (ESTA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Establishment Labs Holdings Inc (ESTA) has a cash flow conversion efficiency ratio of -0.768x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-16.60 Million) by net assets ($21.61 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Establishment Labs Holdings Inc stock valuation for the company's overall valuation and market capitalisation.
Establishment Labs Holdings Inc - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Establishment Labs Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Establishment Labs Holdings Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Establishment Labs Holdings Inc ranked by their cash flow conversion efficiency. Explore ESTA operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Feng Tay Enterprises Co Ltd
TW:9910
|
0.069x |
|
Shanghai Kingstar Winning Software
SHE:300253
|
-0.012x |
|
Cadeler As
OL:CADLR
|
0.148x |
|
Autohome Inc ADR
F:8AHB
|
N/A |
|
Wenzhou Yihua Connector Co Ltd
SHE:002897
|
-0.029x |
|
PSG Konsult Ltd
JSE:KST
|
0.164x |
|
LCI Industries
NYSE:LCII
|
-0.024x |
|
China Southern Airlines Company Limited
F:ZNHH
|
0.192x |
Annual Cash Flow Conversion Efficiency for Establishment Labs Holdings Inc (2016–2025)
The table below shows the annual cash flow conversion efficiency of Establishment Labs Holdings Inc from 2016 to 2025. View current stock price of Establishment Labs Holdings Inc for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $23.55 Million | $-50.89 Million | -2.161x | -96.10% |
| 2024-12-31 | $53.09 Million | $-58.52 Million | -1.102x | +77.10% |
| 2023-12-31 | $18.39 Million | $-88.51 Million | -4.812x | -175.50% |
| 2022-12-31 | $-8.19 Million | $-52.17 Million | 6.373x | +1274.55% |
| 2021-12-31 | $50.74 Million | $-27.53 Million | -0.543x | -225.14% |
| 2020-12-31 | $74.96 Million | $-12.51 Million | -0.167x | +77.95% |
| 2019-12-31 | $39.61 Million | $-29.98 Million | -0.757x | -55.21% |
| 2018-12-31 | $69.48 Million | $-33.88 Million | -0.488x | -107.65% |
| 2017-12-31 | $-5.01 Million | $-31.97 Million | 6.377x | +1081.74% |
| 2016-12-31 | $-26.43 Million | $-14.27 Million | 0.540x | -- |
About Establishment Labs Holdings Inc
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products… Read more